新生隐球菌酚氧化酶的研究进展.pdfVIP

国外医学皮肤性病学分册2003 年第 29 卷第 1 期 39 munity is demonstrable in mice with experimental vaginal candidiasis. immune responses in a rat model of vaginal infection by and protection Infect Immun ,1993 ,61 (5) :1990 - 1995. against Candi da albicans . Infect Immun , 2000 , 68 ( 6 ) : 3297 - 2 Fidel PL J r , L ynch ME , Sobel JD. Effects of preinduced Candida 3304. specific systemic cellmediated immunity on experimental vaginal can 11 Fong IW , McCleary P , Read S. Cellular immunity of patients with didiasis. Infect Immun ,1994 ,62 (3) :1032 - 1038. recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol , ( ) 3 Fidel PL J r , Lynch ME , Sobel JD. Circulating CD4 and CD8 T cells 1992 , 166 3 :887 - 890. have little impact on host defense against experimental vaginal can 12 Nawrot U , GrzybekHryncewicz K , Zielska U , et al. The study of didiasis. Infect Immun ,1995 ,63 (7) :2403 - 2408. cellmediated immune response in recurrent vulvovaginal candidiasis. 4 Cantorna M , Mook D , Balish E. Resistance of congenitally immun FEMS Immunol Med Microbiol ,2000 , 29 (2) :89 - 94. odeficient gnotobiotic mice to vaginal candidiasis. Infect Immun , 13 Fidel PL J r , L ynch ME , Sobel JD. Candidaspecific Th1type re 1990 ,58( 11) :3813 - 3815. sponsiveness in mice with experimental vaginal candidiasis. Infect Im 5 Fidel PL J r , Lynch ME , Conaway DH ,et al. Mice immunized by pri mun , 1993 , 61 ( 10) :4202 - 4207. mary vaginal Candi da albicans infection develop acquired vaginal mu 14 Fidel PL J r , L ynch ME , RedondoLopez V , et al. Systemic cellme cosal immunity. In